ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $315,380 | -7.1% | 3,368 | -11.4% | 0.19% | -4.5% |
Q2 2023 | $339,329 | +24.8% | 3,802 | +49.9% | 0.20% | +34.0% |
Q1 2023 | $271,910 | -10.6% | 2,536 | +1.8% | 0.15% | -5.7% |
Q4 2022 | $304,226 | +1.7% | 2,491 | -14.1% | 0.16% | +33.6% |
Q3 2022 | $299,000 | +12.8% | 2,900 | +1.5% | 0.12% | +21.4% |
Q2 2022 | $265,000 | -16.9% | 2,856 | +4.9% | 0.10% | -31.5% |
Q1 2022 | $319,000 | -12.8% | 2,722 | 0.0% | 0.14% | +3.6% |
Q4 2021 | $366,000 | +45.2% | 2,722 | +72.2% | 0.14% | +24.3% |
Q3 2021 | $252,000 | +15.1% | 1,581 | -5.0% | 0.11% | +23.3% |
Q2 2021 | $219,000 | +3.8% | 1,664 | +1.4% | 0.09% | +1.1% |
Q1 2021 | $211,000 | -21.6% | 1,641 | +1.7% | 0.09% | -20.5% |
Q4 2020 | $269,000 | -21.3% | 1,614 | -27.1% | 0.11% | -37.4% |
Q3 2020 | $342,000 | -7.8% | 2,215 | -11.8% | 0.18% | +1.7% |
Q2 2020 | $371,000 | +5.7% | 2,511 | -19.4% | 0.18% | +22.2% |
Q1 2020 | $351,000 | -29.4% | 3,117 | -12.7% | 0.14% | +77.8% |
Q4 2019 | $497,000 | +146.0% | 3,569 | +70.1% | 0.08% | +97.6% |
Q3 2019 | $202,000 | -20.8% | 2,098 | -5.2% | 0.04% | -24.1% |
Q2 2019 | $255,000 | -49.0% | 2,214 | -47.9% | 0.05% | -94.9% |
Q1 2019 | $500,000 | +66.7% | 4,250 | -11.3% | 1.06% | +1986.3% |
Q4 2018 | $300,000 | – | 4,789 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |